Efficacy and Safety of Adding Immune Checkpoint Inhibitors to Neoadjuvant Chemotherapy Against Triple-Negative Breast Cancer: A Meta-Analysis of Randomized Controlled Trials

BACKGROUND: Immune checkpoint inhibitors (ICIs) have shown promising anti-tumor activity in multiple malignances including breast cancer. However, the responses can vary. This meta-analysis was conducted to evaluate the efficacy and safety profile of adding ICIs to neoadjuvant chemotherapy against t...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yunhai, Xing, Lei, Li, Fan, Liu, Hong, Gan, Lu, Yang, Dejuan, Wang, Mengxue, Yin, Xuedong, Li, Hongyuan, Ren, Guosheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667776/
https://www.ncbi.nlm.nih.gov/pubmed/34912699
http://dx.doi.org/10.3389/fonc.2021.657634

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8667776/
https://www.ncbi.nlm.nih.gov/pubmed/34912699
http://dx.doi.org/10.3389/fonc.2021.657634

Ejemplares similares